Directory
>
Shelley Suggett
Shelley Suggett
Executive Director, Regulatory CMC | NGM Biopharmaceuticals
San Francisco, California, United States
Shelley Suggett
Summary
Shelley Suggett is an accomplished Executive Director in Regulatory CMC at NGM Biopharmaceuticals, with extensive experience in the biopharmaceutical and biotechnology sectors. She has a robust background in biochemistry and has transitioned from academia to industry, focusing on drug development and regulatory affairs. Shelley's work has led to significant contributions in the field, including patents for antibody development and published research in various scientific journals. Her passion for improving patient outcomes is evident in her memorable experiences during clinical trials, such as witnessing the positive impact of Lucentis on a patient's vision. With a strong foundation in both regulatory compliance and supply chain risk management, she is dedicated to leveraging her expertise to drive innovation and deliver value in the pharmaceutical industry. Shelley also serves as an adjunct professor, sharing her knowledge with the next generation of professionals. Her leadership and strategic insights continue to shape the future of drug development.
Shelley Suggett
Work Experience
Executive Director, Regulatory CMC at
NGM Biopharmaceuticals
January 2021 - Present
Adjunct Professor Berkeley Extension at
The University California Berkeley
September 2019 - Present
Principal Consultant at
Themistry, Inc.
January 2019 - December 2021
Adjunct Professor, Dept of Business at
San Francisco State University
January 2019 - October 2021
Senior Director Regulatory Affairs at
Halozyme, Inc.
May 2018 - January 2019
Deputy Director, Global Regulatory Affairs at
Bayer AG
February 2012 - May 2018
Director of Regulatory Affairs at
Peregrine Pharmaceuticals
July 2010 - January 2012
Global Product Supply Chain Leader at
Genentech Foundation
April 2007 - July 2010
Sr Manager/Sr. Scientist, Regulatory Affairs at
Genentech Foundation
August 2000 - April 2007
Research Associate at
Genentech Foundation
May 1995 - August 2000
Research Associate at
J David Gladstone Institutes
December 1992 - December 1994
Research Associate, Immunology, College of Veterinary Medicine at
Uppsala Universitet
August 1991 - June 1992
Shelley Suggett
Education
San Francisco State University, Master Of Business Administration
January 2017 - January 2018
California Polytechnic State University, San Luis Obispo, Bachelor Of Science - Bs
January 1989 - January 1992
Frequently Asked Questions about Shelley Suggett
What is Shelley Suggett email address?
Shelley Suggett's primary email address is ********@ngmbio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Shelley Suggett work for?
Shelley Suggett is a Executive Director, Regulatory CMC at NGM Biopharmaceuticals, a company specializing in Commercial physical research.
Where Shelley Suggett graduated from?
Shelley Suggett holds a degree in Business Administration, Management And Operations from San Francisco State University.
How can I directly contact Shelley Suggett?
To contact Shelley Suggett directly, you can use the email address ********@ngmbio.com. Complete contact information is available upon registration with Muraena.
Who is Shelley Suggett?
Shelley Suggett is an accomplished Executive Director in Regulatory CMC at NGM Biopharmaceuticals, with extensive experience in the biopharmaceutical and biotechnology sectors. She has a robust background in biochemistry and has transitioned from academia to industry, focusing on drug development and regulatory affairs. Shelley's work has led to significant contributions in the field, including patents for antibody development and published research in various scientific journals. Her passion for improving patient outcomes is evident in her memorable experiences during clinical trials, such as witnessing the positive impact of Lucentis on a patient's vision. With a strong foundation in both regulatory compliance and supply chain risk management, she is dedicated to leveraging her expertise to drive innovation and deliver value in the pharmaceutical industry. Shelley also serves as an adjunct professor, sharing her knowledge with the next generation of professionals. Her leadership and strategic insights continue to shape the future of drug development.
Shelley`s contact details
********@ngmbio.com
Colleagues
Vice President, Head of Legal
Executive Director, Project Management
Vice President, CMC & Process Development
VP Head of Biometrics
Chief Scientific Officer
Vice President, Clinical Development
CMO and Executive VP
Director Board Of Directors
Vice President, Clinical Operations